Aflibercept in combination with docetaxel for second line treatment of locally advanced or metastatic non small cell lung cancer NSCLC Final results of a multinational placebo controlled phase III trial EFC10261 VITAL


Novello S., Ramlau R., Gorbunova V., Ciuleanu T., Ozguroglu Ö., GÖKSEL T. , ...Daha Fazla

The 13th World Conference on Lung Cancer, Amsterdam, Hollanda, 3 - 07 Temmuz 2011

  • Basıldığı Şehir: Amsterdam
  • Basıldığı Ülke: Hollanda